Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Employee Service Share-based Compensation Allocation

Total share-based compensation expense included in the condensed consolidated statements of operations and comprehensive loss consisted of the following (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Research and development expense	$	19,480	$	28,276	$	62,518	$	77,343
Selling, general and administrative expense	25,073		14,716		68,395		47,238
	$	44,553	$	42,992	$	130,913	$	124,581